癌治療とＤＤＳ　　癌の遺伝子治療におけるＤＤＳ

DOI 参考文献13件

書誌事項

タイトル別名
  • Drug delivery system for cancer gene therapy-A review.
  • Drug delivery system for cancer gene therapy—A review
  • 癌の遺伝子治療におけるDDS
公開日
2000
DOI
  • 10.2745/dds.15.32
公開者
日本DDS学会

この論文をさがす

説明

Drug delivery system (DDS), currently employed for cancer gene therapy was reviewed. There have been at least four systems hitherto developed to deliver the anticancer genes to tumor. They include 1) modified liposome system such as cationic liposorne, HVJ-liposme, transferrin conjugated liposome etc. 2) naked plasmid DNA conjugated with ligand or antibody which are known to interact with receptor or antigen on tumor cells. 3) viral vectors such as retroviral vector, adenoviral vector, lenti viral vector, adenoassociated viral vector etc. 4) replication competent oncolytic viruses such as E 1 B attenuated adenovirus or genetically modified herpes simplex virus. Although most of these delivery systems are found to be applicable for local administration of transgene, little success has been reported as to specific targeting to tumor by systemic administration. Therefore efforts are now focusing on the development of devise to target tumor in vivo.

収録刊行物

参考文献 (13)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ